US Patent Issued to Janssen Biotech, Yuhan on April 14 for "Therapies with 3rd generation EGFR tyrosine kinase inhibitors" (South Korean Inventors)

ALEXANDRIA, Va., April 15 -- United States Patent no. 12,599,606, issued on April 14, was assigned to Janssen Biotech Inc. (Horsham, Pa.) and Yuhan Corp. (Seoul, South Korea). "Therapies with 3rd gen... Read More

US Patent Issued to The Regents of the University of California, The J. David Gladstone Institutes, a testamentary trust established under the Will of J. David Gladstone on April 14 for "Methods for treating cardiac valve disease" (California Inventors)

ALEXANDRIA, Va., April 15 -- United States Patent no. 12,599,608, issued on April 14, was assigned to The Regents of the University of California (Oakland, Calif.) and The J. David Gladstone Institute... Read More

US Patent Issued to Merck Sharp & Dohme on April 14 for "Solid dosage formulations of an orexin receptor antagonist" (Pennsylvania, New Jersey Inventors)

ALEXANDRIA, Va., April 15 -- United States Patent no. 12,599,610, issued on April 14, was assigned to Merck Sharp & Dohme LLC (Rahway, N.J.). "Solid dosage formulations of an orexin receptor antagoni... Read More

US Patent Issued to Lucolas-M.D. on April 14 for "Pharmaceutical use" (French Inventor)

ALEXANDRIA, Va., April 15 -- United States Patent no. 12,599,612, issued on April 14, was assigned to Lucolas-M.D. Ltd. (Birmingham, Great Britain). "Pharmaceutical use" was invented by Alfred Schmid... Read More

US Patent Issued to MD VAULT on April 14 for "Methods and pharmaceutical compositions for the treatment and prophylaxis of microbial infectious diseases and associated inflammatory disorders and for the treatment and prophylaxis of aging and associated diseases" (Delaware Inventor)

ALEXANDRIA, Va., April 15 -- United States Patent no. 12,599,614, issued on April 14, was assigned to MD VAULT LLC (Lewes, Del.). "Methods and pharmaceutical compositions for the treatment and prophy... Read More

US Patent Issued to ZYDUS LIFESCIENCES on April 14 for "Subtituted sulfonylurea and sulfoximineurea derivatives" (Indian Inventors)

ALEXANDRIA, Va., April 15 -- United States Patent no. 12,599,616, issued on April 14, was assigned to ZYDUS LIFESCIENCES Ltd. (Gujarat, India). "Subtituted sulfonylurea and sulfoximineurea derivative... Read More

US Patent Issued on April 14 for "System and method for aerobic respiratory treatment" (Florida Inventors)

ALEXANDRIA, Va., April 15 -- United States Patent no. 12,599,618, issued on April 14. "System and method for aerobic respiratory treatment" was invented by Jeff Braile (Boca Raton, Fla.) and Morgan P... Read More

US Patent Issued to Vestlandets Innovasjonsselskap AS on April 14 for "Method for the treatment of chronic fatigue syndrome using an inhibitory or cytotoxic agent against plasma cells" (Norwegian Inventors)

ALEXANDRIA, Va., April 15 -- United States Patent no. 12,599,620, issued on April 14, was assigned to Vestlandets Innovasjonsselskap AS (Bergen, Norway). "Method for the treatment of chronic fatigue ... Read More

US Patent Issued to The Brigham and Women's Hospital on April 14 for "Compounds to modulate intestinal absorption of nutrients" (Massachusetts Inventors)

ALEXANDRIA, Va., April 15 -- United States Patent no. 12,599,622, issued on April 14, was assigned to The Brigham and Women's Hospital Inc. (Boston). "Compounds to modulate intestinal absorption of n... Read More

US Patent Issued to Ethicon on April 14 for "Biodegradable lung sealants" (New Jersey Inventors)

ALEXANDRIA, Va., April 15 -- United States Patent no. 12,599,624, issued on April 14, was assigned to Ethicon Inc. (Raritan, N.J.). "Biodegradable lung sealants" was invented by Salim A. Ghodbane (Pi... Read More

• ««
• «
• 14488
• 14489
• 14490
• 14491
• 14492
• 14493
• 14494
• 14495
• 14496
• 14497
• »
• »»